发明名称 Microrna compounds and methods for modulating mir-21 activity
摘要 Described herein are compositions and methods for the inhibition of miR-21 activity. A compound comprising a modified oligonucleotide consisting of 8 to 22 linked nucleosides, wherein the nucleobase sequence of the modified oligonucleotide is complementary to miR-21 (SEQ ID NO: 1) and wherein the modified oligonucleotide comprises at least 8 contiguous nucleosides of the following nucleoside pattern VI, III or IV in the 5’ to 3’ orientation.
申请公布号 NZ630591(A) 申请公布日期 2017.02.24
申请号 NZ20130630591 申请日期 2013.04.24
申请人 Regulus Therapeutics Inc. 发明人 Bhat Balkrishen;Marcusson Eric
分类号 C12N15/113;A61K31/712;A61P13/12;A61P35/00;A61P43/00 主分类号 C12N15/113
代理机构 代理人
主权项
地址